Back

BioHealth Innovation Newsletter - March 2, 2021

posted by BioHealth Capital Fund
1mo ago 213

To view the newsletter click here.

  • Conley Jones, Senior Associate at Alexandria Venture Investments, Guests on BioTalk
  • VIRTUAL SBIR and OTHER NON-DILUTIVE FUNDING SOURCES WORKSHOP with 1:1 PARTNERING – March 17-19, 2021 (2)
  • Digital Health Forum Presented by EAGB and BioHealth Innovation Registration, Thu, Mar 25, 2021 at 1:00 PM | Eventbrite
  • Leveraging Artificial Intelligence in Human Health (March 19) (Bendis to Moderate)
  • Phlow Corp. and USP announce strategic alliance focused on Pharmaceutical Continuous Manufacturing to increase supply of essential medicines for U.S. patients
  • Emergent Rallies to Meet COVID-19 Vaccine Supply Challenge · BioBuzz
  • Altimmune starts enrolling early-stage trial for its nasal spray COVID-19 vaccine candidate - MarketWatch
  • INOVIO and QIAGEN expand collaboration to develop next generation sequencing (NGS) companion diagnostic for INOVIO's VGX-3100 for advanced cervical dysplasia
  • GlycoMimetics Promotes Dr. Eric Feldman to Chief Medical Officer - GlycoMimetics, Inc.
  • New Chief Investment Officer to Lead TEDCO’s Investment Activities | TEDCO
  • Meet the Daily Record’s Power 100 – Maryland Daily Record
  • Novel Microdevices Joins Baltimore’s LaunchPort™ Medtech Venture Center
  • Georgetown Ranks Second Among Top Universities in Women Graduates Who Enter Venture Capital
  • New Funding Can Support Academic Post Doc to Industry Transition


  • GMU establishes President’s Innovation Advisory Council | Virginia Business